UB Paderborn / Katalog / Suche / in CDI

Serpins in thrombosis, hemostasis and fibrinolysis

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (Suppl 1), p.102-115

2007

Link zum Volltext

Verfügbarkeit prüfen

A high affinity, antidote‐controllable prothrombin and thrombin‐binding RNA aptamer inhibits thrombin generation and thrombin activity

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.870-880

2012

Link zum Volltext

Verfügbarkeit prüfen

Protein C inhibitor inhibits factor VIIa when bound to tissue factor

Journal of thrombosis and haemostasis, 2011-04, Vol.9 (4), p.861-863

2011

Link zum Volltext

Verfügbarkeit prüfen

Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel

Thrombosis research, 2012-04, Vol.129, p.S171-S171

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of thrombin exosites in inhibition by heparin cofactor II

The Journal of biological chemistry, 1992-02, Vol.267 (6), p.3613-3617

1992

Link zum Volltext

Verfügbarkeit prüfen

Murine models do not recapitulate the pathophysiology of age‐related venous thrombosis in humans

Journal of thrombosis and haemostasis, 2013-05, Vol.11 (5), p.990-992

2013

Link zum Volltext

Verfügbarkeit prüfen

Role of lysine 173 in heparin binding to heparin cofactor II

The Journal of biological chemistry, 1991-05, Vol.266 (13), p.8129-8135

1991

Link zum Volltext

Verfügbarkeit prüfen

PO-25 Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel

Thrombosis research, 2012-04, Vol.129, p.S171-S171

2012

Link zum Volltext

Verfügbarkeit prüfen

Enhanced cell‐associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1323-1332

2010

Link zum Volltext

Verfügbarkeit prüfen

Is protein C inhibitor antithrombotic and protective in pulmonary hypertension?

Journal of thrombosis and haemostasis, 2006-11, Vol.4 (11), p.2327-2330

2006

Link zum Volltext

Verfügbarkeit prüfen

Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (7), p.1486-1492

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the Glycosaminoglycan-Binding Region of Lactoferrin

Archives of biochemistry and biophysics, 1995-02, Vol.317 (1), p.85-92

1995

Link zum Volltext

Verfügbarkeit prüfen

Role of the γ‐carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin–heparin

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1127-1134

2004

Link zum Volltext

Verfügbarkeit prüfen

Heparin binding to protein C inhibitor

The Journal of biological chemistry, 1992-05, Vol.267 (13), p.8789-8794

1992

Link zum Volltext

Verfügbarkeit prüfen

Interaction of heparin cofactor II with biglycan and decorin

The Journal of biological chemistry, 1993-02, Vol.268 (6), p.3920-3924

1993

Link zum Volltext

Verfügbarkeit prüfen

Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins

Journal of dairy science, 1983-06, Vol.66 (6), p.1219-1227

1983

Link zum Volltext

Verfügbarkeit prüfen

A comparison of three heparin-binding serine proteinase inhibitors

The Journal of biological chemistry, 1992-05, Vol.267 (13), p.8795-8801

1992

Link zum Volltext

Verfügbarkeit prüfen

Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity

The Journal of biological chemistry, 1994-06, Vol.269 (24), p.16696-16700

1994

Link zum Volltext

Verfügbarkeit prüfen

Overview of Blood Coagulation and the Pathophysiology of Blood Coagulation Disorders

Encyclopedia of Cell Biology, 2015, p.714-722

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin

The Journal of biological chemistry, 1993-02, Vol.268 (5), p.3321-3327

1993

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of serine proteases by reactive site mutants of protein C inhibitor (plasminogen activator inhibitor-3)

Fibrinolysis & proteolysis, 1998-09, Vol.12 (5), p.283-291

1998

Link zum Volltext

Verfügbarkeit prüfen

Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptides

The Journal of biological chemistry, 1991-06, Vol.266 (18), p.11975-11979

1991

Link zum Volltext

Verfügbarkeit prüfen

Alpha-galactosidase from Pichia guilliermondii [Fungi]

Mycologia, 1980-03, Vol.72 (2), p.279-287

1980

Link zum Volltext

Verfügbarkeit prüfen

Hydrolysis of milk proteins by immobilized Streptomyces griseus pronase

Journal of dairy science, 1981-01, Vol.64 (5), p.724-731

1981

Link zum Volltext

Verfügbarkeit prüfen

Genetic Moderators of the Impact of Physical Activity on Depressive Symptoms

The Journal of frailty & aging, 2016, Vol.5 (1), p.6-14

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Serpins in thrombosis, hemostasis and fibrinolysis

A high affinity, antidote‐controllable prothrombin and thrombin‐binding RNA aptamer inhibits thrombin generation and thrombin activity

Protein C inhibitor inhibits factor VIIa when bound to tissue factor

Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel

Role of thrombin exosites in inhibition by heparin cofactor II

Murine models do not recapitulate the pathophysiology of age‐related venous thrombosis in humans

Role of lysine 173 in heparin binding to heparin cofactor II

PO-25 Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel

Enhanced cell‐associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells

Is protein C inhibitor antithrombotic and protective in pulmonary hypertension?

Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin

Characterization of the Glycosaminoglycan-Binding Region of Lactoferrin

Role of the γ‐carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin–heparin

Heparin binding to protein C inhibitor

Interaction of heparin cofactor II with biglycan and decorin

Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins

A comparison of three heparin-binding serine proteinase inhibitors

Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity

Overview of Blood Coagulation and the Pathophysiology of Blood Coagulation Disorders

Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin

Inhibition of serine proteases by reactive site mutants of protein C inhibitor (plasminogen activator inhibitor-3)

Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptides

Alpha-galactosidase from Pichia guilliermondii [Fungi]

Hydrolysis of milk proteins by immobilized Streptomyces griseus pronase

Genetic Moderators of the Impact of Physical Activity on Depressive Symptoms

Suchergebnisse filtern